LYMPHAX
Live / Applied — Third extension granted (statement of use) (as of 11 Sept 2026)
What this means for you
Not registered yet, but its 26 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98668972
- Mark type
- Stylized text
- Filed
- 26 Jul 2024
- Published for opposition
- 18 Mar 2025
- Attorney of record
- Muzamil Huq
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of treating ophthalmic disorders; Research and development in the pharmaceutical and biotechnology fields; Research and development of medicines; Research and development of siRNA drugs; Research and development services of new pharmaceutical products; Pharmaceutical research and development
Owner
- Lymphax, Inc., Carlsbad, CA, US
- Lymphax, Inc., Carlsbad, CA, US
Prosecution history
- 11 Sept 2026 — SOU EXTENSION 3 GRANTED
- 11 Sept 2026 — SOU EXTENSION 3 FILED
- 11 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 27 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Mar 2026 — SOU EXTENSION 2 GRANTED
- 26 Mar 2026 — SOU EXTENSION 2 FILED
- 26 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 06 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Nov 2025 — SOU EXTENSION 1 GRANTED
- 05 Nov 2025 — SOU EXTENSION 1 FILED
- 05 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT